Inke S.A: APIs manufacturing plant.
01 1INKE SA
02 1Dr. Reddy's Laboratories Limited
03 1AX Pharmaceutical Corp
04 1Aurobindo Pharma Limited
05 1Cadila Pharmaceuticals Limited
06 4Cambrex Charles City, Inc
07 1Cipla Ltd.
08 1HIKAL LIMITED
09 1Ipca Laboratories Limited
10 1LETCO MEDICAL, LLC
11 1Medisca Inc.
12 1Natco Pharma Limited
13 2Professional Compounding Centers of America dba PCCA
14 1SMS Pharmaceuticals Limited
15 1ScinoPharm Taiwan Ltd.
16 1Symed Labs Limited
17 1TAPI Hungary Industries Kft.
18 1Teva Pharmaceutical Works Private Limited Company
01 4ONDANSETRON HYDROCHLORIDE
02 1Ondansetron
03 1Ondansetron HCl
04 1Ondansetron HCl Dihydrate
05 14Ondansetron Hydrochloride
06 1Ondansetron Hydrochloride Dihydrate
01 1Canada
02 9India
03 1Israel
04 1Spain
05 1Taiwan
06 6U.S.A
07 2United Kingdom
08 1Blank
Inke S.A: APIs manufacturing plant.
NDC Package Code : 64567-0005
Start Marketing Date : 2009-08-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-017
Start Marketing Date : 2010-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-1851
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-1850
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7540
Start Marketing Date : 2018-11-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-1153
Start Marketing Date : 2019-11-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2415
Start Marketing Date : 2007-06-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0075
Start Marketing Date : 2020-07-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-4320
Start Marketing Date : 2008-10-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51846-1025
Start Marketing Date : 2017-11-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
A Ondansetron Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ondansetron Hydrochloride, including repackagers and relabelers. The FDA regulates Ondansetron Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ondansetron Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ondansetron Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ondansetron Hydrochloride supplier is an individual or a company that provides Ondansetron Hydrochloride active pharmaceutical ingredient (API) or Ondansetron Hydrochloride finished formulations upon request. The Ondansetron Hydrochloride suppliers may include Ondansetron Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Ondansetron Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ondansetron Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ondansetron Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ondansetron Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ondansetron Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ondansetron Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ondansetron Hydrochloride suppliers with NDC on PharmaCompass.
We have 17 companies offering Ondansetron Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
